Abstract
Parkinsons disease is a chronic neurodegenerative disease, the diagnosis of which remains challenging at the early stages, although clinical diagnostic criteria are developed. The diagnostic accuracy is only 58% for patients at early Parkinsons disease stages. The sensitivity and specificity of transcranial sonography of the substantia nigra used for Parkinsons disease verification is about 85% and 71%, respectively. It has been shown that the aggregates of -synuclein in the nerve fibers in major salivary glands may be seen in Parkinsons disease patients. The availability of the salivary glands for morphological study made it possible to investigate the approaches of the in vivo histological diagnosis of Parkinsons disease based on the detection of -synuclein aggregates in the nerve fibers innervating the glands.
Aim: To evaluate and compare the sensitivity of transcranial sonography of the substantia nigra and sublingual salivary gland biopsy.
Materials and methods: Six patients with clinically verified Parkinsons disease were enrolled. Evaluation of the neurological state using special scales, transcranial sonography of the substantia nigra and sublingual salivary gland biopsy was performed.
Results: Mean age of patients was 59 [58; 60.7] years, mean disease duration period was 5 [3; 7.75] years and the mean HoehnYahr stage was 2.25 [2; 2.5]. Hyperechogenicity of the substantia nigra was found in 3 of 6 patients and the substantia nigra sensitivity was shown to be 50%. Sublingual salivary gland biopsy was positive for -synuclein in 6 of 6 patients and the sensitivity of method was shown to be 100%. No adverse events after biopsy were registered.
Conclusion: The sensitivity of sublingual salivary gland biopsy was higher than those of transcranial sonography of the substantia nigra, which indicates the prospect of using the biopsy method as a more sensitive diagnostic tool in Parkinsons disease (1 table, bibliography: 19 refs)
Reference19 articles.
1. Razdorskaya VV, Voskresenskaya ON, Yudina GK. Parkinson’s disease in Russia: prevalence and incidence. Saratov Journal of Medical Scientific Research. 2016;12(3):379–384. (In Russ.)
2. Illarioshkin SN. Parkinson’s disease course and approaches to early diagnosis. In: Illarioshkin SN, Levin OS, eds. Parkinson’s disease and movement disorders. A guide for physicians based on the materials of the II National Congress. Moscow: Serebryanye niti Publisher; 2011: 41–47. (In Russ.)
3. Gopalakrishna A, Alexander SA. Understanding Parkinson disease: a complex and multifaceted illness. J Neurosci Nurs. 2015;47(6):320–326.
4. Alekseeva NS, Illarioshkin SN, Ponomareva TA, Fedotova EYu, Ivanova-Smolenskaya IA. Smell disorders in Parkinson’s disease. Neurological Journal. 2012;17(1):10–14. (In Russ.)
5. The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease